Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 395

1.

Where are the gaps in education in the field of rare lung disease? Perspectives from the ERN-LUNG educational programme survey.

Powell P, Kreuter M, Wijsenbeek-Lourens M.

Breathe (Sheff). 2019 Jun;15(2):102-103. doi: 10.1183/20734735.0120-2019.

2.

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).

Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M.

BMJ Open Respir Res. 2019 May 21;6(1):e000422. doi: 10.1136/bmjresp-2019-000422. eCollection 2019.

3.

Steps Toward Scalability: Illustrations From a Smoke-Free Homes Program.

Kegler MC, Haardörfer R, Melanson T, Allen L, Bundy LT, Kreuter MW, Williams RS, Hovell MF, Mullen PD.

Health Educ Behav. 2019 Jun 5:1090198119848767. doi: 10.1177/1090198119848767. [Epub ahead of print]

PMID:
31165637
4.

Digital Lung Auscultation: Will Early Diagnosis of Fibrotic Interstitial Lung Disease Become a Reality?

Richeldi L, Cottin V, Würtemberger G, Kreuter M, Calvello M, Sgalla G.

Am J Respir Crit Care Med. 2019 May 31. doi: 10.1164/rccm.201902-0306LE. [Epub ahead of print] No abstract available.

PMID:
31150267
5.

Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.

Frank AL, Kreuter M, Schwarzkopf L.

Respir Med. 2019 Jun;152:25-31. doi: 10.1016/j.rmed.2019.04.009. Epub 2019 Apr 22.

PMID:
31128606
6.

The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis.

Cottin V, Annesi-Maesano I, Günther A, Galvin L, Kreuter M, Powell P, Prasse A, Reynolds G, Richeldi L, Spagnolo P, Valenzuela C, Wijsenbeek M, Wuyts WA, Crestani B; Ariane-IPF Clinical Research Collaboration consortium.

Eur Respir J. 2019 May 23;53(5). pii: 1900539. doi: 10.1183/13993003.00539-2019. Print 2019 May. No abstract available.

PMID:
31123022
7.

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.

Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L.

Lancet Respir Med. 2019 May 17. pii: S2213-2600(19)30172-9. doi: 10.1016/S2213-2600(19)30172-9. [Epub ahead of print]

PMID:
31122893
8.

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C.

Eur Respir J. 2019 May 9;53(5). pii: 1900615. doi: 10.1183/13993003.00615-2019. Print 2019 May. No abstract available.

PMID:
31072878
9.

Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis.

Kreuter M, Lederer DJ, Molina-Molina M, Noth I, Valenzuela C, Frankenstein L, Weycker D, Atwood M, Kirchgaessler KU, Cottin V.

Chest. 2019 Apr 29. pii: S0012-3692(19)30882-7. doi: 10.1016/j.chest.2019.04.015. [Epub ahead of print]

10.

Effects of an Oil-Free Hydroethanolic Pumpkin Seed Extract on Symptom Frequency and Severity in Men with Benign Prostatic Hyperplasia: A Pilot Study in Humans.

Leibbrand M, Siefer S, Schön C, Perrinjaquet-Moccetti T, Kompek A, Csernich A, Bucar F, Kreuter MH.

J Med Food. 2019 Jun;22(6):551-559. doi: 10.1089/jmf.2018.0106. Epub 2019 Apr 24.

PMID:
31017505
11.

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials.

Kreuter M, Koegler H, Trampisch M, Geier S, Richeldi L.

Respir Res. 2019 Apr 11;20(1):71. doi: 10.1186/s12931-019-1037-7.

12.

Can monocytes predict prognosis of idiopathic pulmonary fibrosis?

Kreuter M, Maher TM.

Lancet Respir Med. 2019 Jun;7(6):467-469. doi: 10.1016/S2213-2600(19)30050-5. Epub 2019 Mar 29. No abstract available.

13.

Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 Deficiency.

Egenlauf B, Schuhmann M, Giese T, Junghanss T, Stojkovic M, Tintelnot K, de Hoog S, Greil J, Richter E, Vehresschild M, Heussel CP, Herth FJF, Kreuter M.

Respiration. 2019;97(5):472-475. doi: 10.1159/000493429. Epub 2019 Mar 29.

PMID:
30928982
14.

Utility of Anti-DSF70 Antibodies to Predict Connective Tissue Disease in Patients Originally Presenting with Idiopathic Interstitial Pneumonia.

Lyu Y, Boerner E, Theegarten D, Guzman J, Kreuter M, Costabel U, Bonella F.

Respiration. 2019 Mar 29:1-9. doi: 10.1159/000496483. [Epub ahead of print]

PMID:
30928980
15.

Improving Adherence to Colorectal Cancer Screening: A Randomized Intervention to Compare Screener vs. Survivor Narratives.

McQueen A, Caburnay C, Kreuter M, Sefko J.

J Health Commun. 2019;24(2):141-155. doi: 10.1080/10810730.2019.1587109. Epub 2019 Mar 29.

PMID:
30924402
16.

Specialized tobacco quitline and basic needs navigation interventions to increase cessation among low income smokers: Study protocol for a randomized controlled trial.

McQueen A, Roberts C, Garg R, Caburnay C, Fu Q, Gordon J, Bush T, Pokojski R, Thompson T, Kreuter M.

Contemp Clin Trials. 2019 May;80:40-47. doi: 10.1016/j.cct.2019.03.009. Epub 2019 Mar 20.

PMID:
30904596
17.

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J.

Respir Res. 2019 Mar 15;20(1):59. doi: 10.1186/s12931-019-1020-3.

18.

[Acute hemoptysis and crazy-paving pattern].

Wagner WL, Rothermel A, Optazaite DE, Schneider D, Kreuter M, Kauczor HU, Heußel CP.

Med Klin Intensivmed Notfmed. 2019 Feb 25. doi: 10.1007/s00063-019-0554-y. [Epub ahead of print] German. No abstract available.

PMID:
30805661
19.

Research highlights from the 2018 ERS International Congress: interstitial lung diseases.

Alfaro TM, Moor CC, Alfieri V, Jeny F, Kreuter M, Wijsenbeek MS, Renzoni EA, Bargagli E, Nunes H, Spagnolo P, Bonella F, Molina-Molina M, Antoniou K, Poletti V.

ERJ Open Res. 2019 Feb 18;5(1). pii: 00215-2018. doi: 10.1183/23120541.00215-2018. eCollection 2019 Feb. Review.

20.

Corrigendum to "Perceived social support in African American breast cancer patients: Predictors and effects" [Soc. Sci. Med. 192 (2017) 134-142].

Thompson T, Pérez M, Kreuter M, Margenthaler J, Colditz G, Jeffe DB.

Soc Sci Med. 2019 Feb;223:117-120. doi: 10.1016/j.socscimed.2019.01.030. Epub 2019 Feb 1. No abstract available.

21.

Social Needs and Health-Related Outcomes Among Medicaid Beneficiaries.

Thompson T, McQueen A, Croston M, Luke A, Caito N, Quinn K, Funaro J, Kreuter MW.

Health Educ Behav. 2019 Jun;46(3):436-444. doi: 10.1177/1090198118822724. Epub 2019 Jan 17.

PMID:
30654655
22.

Effect of a chamomile extract in protecting against radiation-induced intestinal mucositis.

Khayyal MT, Kreuter MH, Kemmler M, Altmann P, Abdel-Naby DH, El-Ghazaly MA.

Phytother Res. 2019 Mar;33(3):728-736. doi: 10.1002/ptr.6263. Epub 2019 Jan 10.

PMID:
30632234
23.

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study.

Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C.

Eur Respir J. 2019 Mar 7;53(3). pii: 1801587. doi: 10.1183/13993003.01587-2018. Print 2019 Mar.

PMID:
30578385
24.

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases.

Holtze C, Flaherty K, Kreuter M, Luppi F, Moua T, Vancheri C, Scholand MB.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180078. doi: 10.1183/16000617.0078-2018. Print 2018 Dec 31. Review.

25.

Transbronchial Cryobiopsies for Diagnosing Interstitial Lung Disease: Real-Life Experience from a Tertiary Referral Center for Interstitial Lung Disease.

Wälscher J, Groß B, Eberhardt R, Heussel CP, Eichinger M, Warth A, Lasitschka F, Herth FJF, Kreuter M.

Respiration. 2019;97(4):348-354. doi: 10.1159/000493428. Epub 2018 Dec 14.

PMID:
30554201
26.

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

Bendstrup E, Wuyts W, Alfaro T, Chaudhuri N, Cornelissen R, Kreuter M, Melgaard Nielsen K, Münster AB, Myllärniemi M, Ravaglia C, Vanuytsel T, Wijsenbeek M.

Respiration. 2019;97(2):173-184. doi: 10.1159/000495046. Epub 2018 Dec 13. Review.

PMID:
30544129
27.

[Sirolimus for LAM - A New MILEStone Reached?]

Kreuter M, Wirtz H.

Pneumologie. 2019 Jan;73(1):22-23. doi: 10.1055/a-0802-3633. Epub 2018 Dec 12. German. No abstract available.

PMID:
30541159
28.

Disseminating a Smoke Free Homes program to low SES households in the US through 2-1-1: Results of a national impact evaluation.

Bundy LT, Haardörfer R, Kegler MC, Owolabi S, Berg CJ, Escoffery C, Thompson T, Mullen PD, Williams R, Hovell M, Kahl T, Harvey D, Price A, House D, Booker BW, Kreuter MW.

Nicotine Tob Res. 2018 Dec 5. doi: 10.1093/ntr/nty256. [Epub ahead of print]

PMID:
30517679
29.

Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.

Flechsig P, Hural O, Kreuter M, Eichhorn M, HEUßEL G, Sachpekidis C, Kauczor HU, Haberkorn U, Heussel CP, Eichinger M.

In Vivo. 2018 Nov-Dec;32(6):1457-1462. doi: 10.21873/invivo.11399.

30.

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Uncertainties and Controversies.

Wang Z, Bonella F, Li W, Boerner EB, Guo Q, Kong X, Zhang X, Costabel U, Kreuter M.

Respiration. 2018;96(6):571-587. doi: 10.1159/000492336. Epub 2018 Oct 11. Review.

PMID:
30308515
31.

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.

Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Cottin V.

BMJ Open Respir Res. 2018 Sep 4;5(1):e000289. doi: 10.1136/bmjresp-2018-000289. eCollection 2018.

32.

Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.

Crestani B, Huggins JT, Kaye M, Costabel U, Glaspole I, Ogura T, Song JW, Stansen W, Quaresma M, Stowasser S, Kreuter M.

Lancet Respir Med. 2019 Jan;7(1):60-68. doi: 10.1016/S2213-2600(18)30339-4. Epub 2018 Sep 14.

PMID:
30224318
33.

Should Patients With Interstitial Lung Disease Be Seen by Experts?

Cottin V, Castillo D, Poletti V, Kreuter M, Corte TJ, Spagnolo P.

Chest. 2018 Sep;154(3):713-714. doi: 10.1016/j.chest.2018.05.044. No abstract available.

PMID:
30195349
34.

Interstitial lung diseases: course report.

Kreuter M, Calaras D.

Breathe (Sheff). 2018 Sep;14(3):184-185. doi: 10.1183/20734735.019718.

35.

Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis.

Kwapiszewska G, Gungl A, Wilhelm J, Marsh LM, Thekkekara Puthenparampil H, Sinn K, Didiasova M, Klepetko W, Kosanovic D, Schermuly RT, Wujak L, Weiss B, Schaefer L, Schneider M, Kreuter M, Olschewski A, Seeger W, Olschewski H, Wygrecka M.

Eur Respir J. 2018 Nov 22;52(5). pii: 1800564. doi: 10.1183/13993003.00564-2018. Print 2018 Nov.

36.

Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views.

Maher TM, Swigris JJ, Kreuter M, Wijsenbeek M, Cassidy N, Ireland L, Axmann J, Nathan SD.

Respiration. 2018;96(6):514-524. doi: 10.1159/000490667. Epub 2018 Aug 16.

PMID:
30114692
37.

Moderators of Establishing a Smoke-Free Home: Pooled Data from Three Randomized Controlled Trials of a Brief Intervention.

Kegler MC, Haardörfer R, Bundy LT, Escoffery C, Williams RS, Hovell M, Kreuter M, Mullen PD.

J Community Health. 2019 Feb;44(1):121-126. doi: 10.1007/s10900-018-0561-6.

PMID:
30101386
38.

A Face-Aging Smoking Prevention/Cessation Intervention for Nursery School Students in Germany: An Appearance-Focused Interventional Study.

Brinker TJ, Alfitian J, Seeger W, Groneberg DA, von Kalle C, Enk AH, Herth FJF, Kreuter M, Bauer CM, Gatzka M, Suhre JL.

Int J Environ Res Public Health. 2018 Aug 4;15(8). pii: E1656. doi: 10.3390/ijerph15081656.

39.

Gazing into the crystal ball: can treatment response be predicted in IPF?

Kreuter M, Maher T.

Lancet Respir Med. 2018 Aug;6(8):570-572. doi: 10.1016/S2213-2600(18)30234-0. Epub 2018 Jun 29. No abstract available.

40.

Perceptions of Health Coaching for Behavior Change Among Medicaid and Commercially Insured Adults.

McQueen A, Kreuter M, Loughran M, Thompson T, Poor T.

Health Promot Pract. 2018 Aug 1:1524839918790936. doi: 10.1177/1524839918790936. [Epub ahead of print]

PMID:
30064265
41.

Management of Spontaneous Pneumothorax and Postinterventional Pneumothorax: German S3-Guideline.

Schnell J, Beer M, Eggeling S, Gesierich W, Gottlieb J, Herth F, Hofmann HS, Jany B, Kreuter M, Ley-Zaporozhan J, Scheubel R, Walles T, Wiesemann S, Worth H, Stoelben E.

Zentralbl Chir. 2018 Aug;143(S 01):S12-S43. doi: 10.1055/a-0588-4444. Epub 2018 Jul 24. English, German.

PMID:
30041262
42.

Management of Spontaneous Pneumothorax and Post-Interventional Pneumothorax: German S3 Guideline.

Schnell J, Beer M, Eggeling S, Gesierich W, Gottlieb J, Herth FJF, Hofmann HS, Jany B, Kreuter M, Ley-Zaporozhan J, Scheubel R, Walles T, Wiesemann S, Worth H, Stoelben E.

Respiration. 2019;97(4):370-402. doi: 10.1159/000490179. Epub 2018 Jul 24.

PMID:
30041191
43.

Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis.

Spagnolo P, Kreuter M, Maher TM, Wuyts W, Bonella F, Corte TJ, Kopf S, Weycker D, Kirchgaessler KU, Ryerson CJ.

Respiration. 2018;96(4):314-322. doi: 10.1159/000489668. Epub 2018 Jul 19.

PMID:
30025392
44.

Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.

Vancheri C, Kreuter M, Richeldi L, Quaresma M, Stowasser S, Wuyts WA.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1105-1106. doi: 10.1164/rccm.201806-1116LE. No abstract available.

PMID:
30025211
45.

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent.

Kreuter M, Raghu G.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800921. doi: 10.1183/13993003.00921-2018. Print 2018 Jun. No abstract available.

PMID:
29929960
46.

Breathlessness and Restrictive Lung Disease: An Important Diabetes-Related Feature in Patients with Type 2 Diabetes.

Kopf S, Groener JB, Kender Z, Fleming T, Brune M, Riedinger C, Volk N, Herpel E, Pesta D, Szendrödi J, Wielpütz MO, Kauczor HU, Katus HA, Kreuter M, Nawroth PP.

Respiration. 2018;96(1):29-40. doi: 10.1159/000488909. Epub 2018 Jun 6.

PMID:
29874679
47.

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.

Szentes BL, Kreuter M, Bahmer T, Birring SS, Claussen M, Waelscher J, Leidl R, Schwarzkopf L.

Respir Res. 2018 May 25;19(1):101. doi: 10.1186/s12931-018-0808-x.

48.

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.

Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L.

JAMA. 2018 Jun 12;319(22):2299-2307. doi: 10.1001/jama.2018.6129.

49.

What would help low-income families?: Results from a North American survey of 2-1-1 helpline professionals.

Thompson T, Roux AM, Kohl PL, Boyum S, Kreuter MW.

J Child Health Care. 2018 Jan 1:1367493518777152. doi: 10.1177/1367493518777152. [Epub ahead of print]

PMID:
29788775
50.

Cessation and reduction in smoking behavior: impact of creating a smoke-free home on smokers.

Haardörfer R, Kreuter M, Berg CJ, Escoffery C, Bundy LT, Hovell M, Mullen PD, Williams R, Kegler MC.

Health Educ Res. 2018 Jun 1;33(3):256-259. doi: 10.1093/her/cyy014.

PMID:
29788227

Supplemental Content

Loading ...
Support Center